Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devanand Sarkar

Showing results (21-30 of 289) with videos related to

Pageof 29
Sort By:
Cancers|January 21, 2023
Gene Screening for Prognosis of Non-Muscle-Invasive Bladder Carcinoma under Competing Risks EndpointsChenlu Ke, Dipankar Bandyopadhyay, Devanand Sarkar
Advances in Cancer Research|August 6, 2021
Astrocyte elevated gene-1 (AEG-1): A key driver of hepatocellular carcinoma (HCC)Indranil Banerjee, Paul B Fisher, Devanand Sarkar
Oncotarget|February 19, 2019
AEG-1 targeting for inhibiting inflammation: potential anti-HCC strategySaranya Chidambaranathan Reghupaty, Rachel Mendoza, Devanand Sarkar
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2008
Evolution of MDA-5/RIG-I-dependent innate immunity: independent evolution by domain graftingDevanand Sarkar, Rob Desalle, Paul B Fisher
Cancers|April 26, 2025
Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH): A Promising Molecular Marker and Therapeutic Target for Hepatocellular CarcinomaEva Davis, Ali Gawi Ermi, Devanand Sarkar
Pigment Cell & Melanoma Research|November 13, 2010
Stress-sensing toll-like receptor as a driver of angiogenesisXiang-Yang Wang, Devanand Sarkar, Paul B Fisher
Cell Cycle (Georgetown, Tex.)|October 28, 2011
Targeting JunD: a potential strategy to counteract hormone-refractory prostate cancerDevanand Sarkar, Xiang-Yang Wang, Paul B Fisher
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2008
Reciprocal subtraction differential RNA display (RSDD): an efficient technology for cloning differentially expressed genesDevanand Sarkar, Dong-chul Kang, Paul B Fisher
Advances in Cancer Research|February 13, 2021
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classificationSaranya Chidambaranathan-Reghupaty, Paul B Fisher, Devanand Sarkar
Cell Cycle (Georgetown, Tex.)|July 25, 2006
Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): efficacious reagents for cancer gene therapyDevanand Sarkar, Zao-Zhong Su, Paul B Fisher
Pageof 29

Showing results (21-30 of 289) with videos related to

Sort By:
Pageof 29
Cancers|January 21, 2023
Gene Screening for Prognosis of Non-Muscle-Invasive Bladder Carcinoma under Competing Risks EndpointsChenlu Ke, Dipankar Bandyopadhyay, Devanand Sarkar
Advances in Cancer Research|August 6, 2021
Astrocyte elevated gene-1 (AEG-1): A key driver of hepatocellular carcinoma (HCC)Indranil Banerjee, Paul B Fisher, Devanand Sarkar
Oncotarget|February 19, 2019
AEG-1 targeting for inhibiting inflammation: potential anti-HCC strategySaranya Chidambaranathan Reghupaty, Rachel Mendoza, Devanand Sarkar
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2008
Evolution of MDA-5/RIG-I-dependent innate immunity: independent evolution by domain graftingDevanand Sarkar, Rob Desalle, Paul B Fisher
Cancers|April 26, 2025
Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH): A Promising Molecular Marker and Therapeutic Target for Hepatocellular CarcinomaEva Davis, Ali Gawi Ermi, Devanand Sarkar
Pigment Cell & Melanoma Research|November 13, 2010
Stress-sensing toll-like receptor as a driver of angiogenesisXiang-Yang Wang, Devanand Sarkar, Paul B Fisher
Cell Cycle (Georgetown, Tex.)|October 28, 2011
Targeting JunD: a potential strategy to counteract hormone-refractory prostate cancerDevanand Sarkar, Xiang-Yang Wang, Paul B Fisher
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2008
Reciprocal subtraction differential RNA display (RSDD): an efficient technology for cloning differentially expressed genesDevanand Sarkar, Dong-chul Kang, Paul B Fisher
Advances in Cancer Research|February 13, 2021
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classificationSaranya Chidambaranathan-Reghupaty, Paul B Fisher, Devanand Sarkar
Cell Cycle (Georgetown, Tex.)|July 25, 2006
Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): efficacious reagents for cancer gene therapyDevanand Sarkar, Zao-Zhong Su, Paul B Fisher
Pageof 29